Meyka Pro banner
Paion AG

Paion AG Fundamental Analysis (XETRA: PA8.DE)

PA8.DEXETRA
HealthcareDrug Manufacturers - Specialty & Generic
0.36
0.02(4.35%)
German Market opens in 5h 40m

Paion AG Fundamental Analysis (XETRA: PA8.DE)

Paion AG (XETRA: PA8.DE) shows weak financial fundamentals with a PE ratio of -4.43, profit margin of -1.74%, and ROE of -8.51%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position413.86%
PEG Ratio0.05

Areas of Concern

ROE-8.51%
Operating Margin4.53%
We analyze PA8.DE's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -2.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-2.3/100

We analyze PA8.DE's fundamental strength across five key dimensions:

Efficiency Score

Weak

PA8.DE struggles to generate sufficient returns from assets.

ROA > 10%
-1.52%

Valuation Score

Excellent

PA8.DE trades at attractive valuation levels.

PE < 25
-4.43
PEG Ratio < 2
0.05

Growth Score

Weak

PA8.DE faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

PA8.DE shows balanced financial health with some risks.

Debt/Equity < 1
3.08
Current Ratio > 1
1.41

Profitability Score

Weak

PA8.DE struggles to sustain strong margins.

ROE > 15%
-850.59%
Net Margin ≥ 15%
-1.74%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is PA8.DE Expensive or Cheap?

P/E Ratio

PA8.DE trades at -4.43 times earnings. This suggests potential undervaluation.

-4.43

PEG Ratio

When adjusting for growth, PA8.DE's PEG of 0.05 indicates potential undervaluation.

0.05

Price to Book

The market values Paion AG at 0.39 times its book value. This may indicate undervaluation.

0.39

EV/EBITDA

Enterprise value stands at -1.95 times EBITDA. This is generally considered low.

-1.95

How Well Does PA8.DE Make Money?

Net Profit Margin

For every $100 in sales, Paion AG keeps $-1.74 as profit after all expenses.

-1.74%

Operating Margin

Core operations generate 4.53 in profit for every $100 in revenue, before interest and taxes.

4.53%

ROE

Management delivers $-8.51 in profit for every $100 of shareholder equity.

-8.51%

ROA

Paion AG generates $-1.52 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.52%

Following the Money - Real Cash Generation

Operating Cash Flow

Paion AG produces operating cash flow of $6.27M, showing steady but balanced cash generation.

$6.27M

Free Cash Flow

Paion AG generates strong free cash flow of $4.59M, providing ample flexibility for dividends, buybacks, or growth.

$4.59M

FCF Per Share

Each share generates $0.61 in free cash annually.

$0.61

FCF Yield

PA8.DE converts 1.61% of its market value into free cash.

1.61%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-4.43

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.05

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.39

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.08

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

3.08

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.41

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.09

vs 25 benchmark

ROA

Return on assets percentage

-0.02

vs 25 benchmark

ROCE

Return on capital employed

0.06

vs 25 benchmark

How PA8.DE Stacks Against Its Sector Peers

MetricPA8.DE ValueSector AveragePerformance
P/E Ratio-4.4332.02 Better (Cheaper)
ROE-8.51%569.00% Weak
Net Margin-1.74%29961.00% Weak
Debt/Equity3.080.53 Weak (High Leverage)
Current Ratio1.415.67 Neutral
ROA-1.52%-96.00% (disorted) Weak

PA8.DE outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Paion AG's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ